PATENT CLAIM ANALYSIS

Application Number: 15937725
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["552", "615000"]

Abstract:
The invention relates to a 17α-alkynyl-androst-5-ene-3β,7β,17β-triol compound essentially free of steroid side-product lacking an oxygen substituent at position 7 and processes for preparing the same.

Claim (Index 12):
The compound of  claim 8 , wherein R 5  is \u2014CH 3 .

Metadata:
- Claim Count in Document: 50.0
- Percentile: 90.0
- Lexical Diversity: 1.0
- Patent Class: 552.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12479626', '14886738', '13664304', '15348107', '14459528']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7691939727548396
- 35 USC 102 Novelty (BERT): 0.7116192826831786
- Combined Prediction Score: 0.7634365037476736
- Mean Citation Score: 540.2077939999998
- Max Citation Score: 642.5684
- Similarity Product: 583.4957643673897

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test